Frequency of K-ras mutations in pancreatic intraductal neoplasias associated with pancreatic ductal adenocarcinoma and chronic pancreatitis: a meta-analysis.
Molecular analyses have demonstrated mutations in the K-ras gene at codon 12 in the majority of pancreatic ductal adenocarcinomas (PDACs). In order to determine whether the K-ras mutation rate increases parallel to the grade of dysplasia in duct lesions, we performed a meta-analysis of the studies published between 1988 and 2003 that provide information on K-ras mutations in hyperplastic and dysplastic duct lesions in the pancreas. The described duct lesions were reclassified according to the nomenclature for pancreatic intraepithelial neoplasia (PanIN), and the molecular methods for detecting K-ras were reviewed. In PanIN lesions from pancreata of patients with PDAC, there was a stepwise increase in K-ras mutations that correlated with the grade of dysplasia of the PanIN lesion. K-ras mutations were found in 36%, 44%, and 87% of PanIN-1a, 1b, and 2-3 lesions, respectively (trend statistic P <.001). Mutation-enriched polymerase chain reaction (PCR) resulted in higher rates of K-ras mutations in PanIN than plain PCR did. The incidence of K-ras mutations in PanIN lesions associated with chronic pancreatitis (CP) or normal pancreas was low (around 10%). In CP, K-ras mutations were only found after a disease duration of 3 years. The correlation of the incidence of K-ras mutations with the grade of dysplasia in PanIN and the occurrence of these mutations in CP with a duration of more than 3 years underlines the importance of this genetic change for the development of PDAC.
Löhr
Matthias
M
Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany. matthias.loehr@med.ma.uni-heidelberg.de
Klöppel
Günter
G
Maisonneuve
Patrick
P
Lowenfels
Albert B
AB
Lüttges
Jutta
J
D000230:Adenocarcinoma / Q000235:genetics; D021441:Carcinoma, Pancreatic Ductal / Q000235:genetics*; D011905:Genes, ras / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000235:genetics*; D010183:Pancreatic Ducts / Q000473:pathology*; D010190:Pancreatic Neoplasms / Q000235:genetics* / Q000473:pathology; D010195:Pancreatitis / Q000235:genetics*
Am J Pathol. 2002 Nov;161(5):1541-7
12414502
Nature. 1999 Jul 29;400(6743):464-8
10440377
Gastroenterology. 2003 Jun;124(7):1958-64
12806629
Eur J Surg Oncol. 2003 Aug;29(6):491-6
12875854
Pancreas. 2003 Oct;27(3):e57-62
14508142
Int J Cancer. 2003 Nov 20;107(4):635-41
14520703
Mod Pathol. 2003 Oct;16(10):996-1006
14559982
Virchows Arch. 2003 Oct;443(4):508-17
12942322
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14247-52
14603032
Am J Surg Pathol. 2003 Dec;27(12):1495-501
14657708
Cancer Cell. 2003 Dec;4(6):437-50
14706336
Curr Gastroenterol Rep. 2004 Apr;6(2):111-8
15191688
Carcinogenesis. 2004 Jul;25(7):1243-7
14963016
Int J Cancer. 2004 Sep 10;111(4):480-3
15239123
Mol Cancer. 2003 Jan 7;2:7
12537585
Gastroenterology. 1992 Jan;102(1):230-6
1309358
Ann Surg. 1993 Feb;217(2):138-43
8439212
Cancer Res. 1993 Mar 1;53(5):953-6
8439969
Am J Pathol. 1993 Aug;143(2):545-54
8342602
Int J Pancreatol. 1993 Dec;14(3):237-44
8113625
BMJ. 1994 Sep 10;309(6955):648-51
8086990
Gastroenterology. 1996 Jan;110(1):227-31
8536861
Gastroenterology. 1996 Jan;110(1):306-10
8536876
Jpn J Cancer Res. 1999 Aug;90(8):841-8
10543256
Virchows Arch. 1999 Nov;435(5):461-8
10592048
J Epidemiol Community Health. 1999 Nov;53(11):702-9
10656099
Cancer Res. 2000 Apr 1;60(7):2002-6
10766191
Am J Pathol. 2000 May;156(5):1767-71
10793087
Histopathology. 2000 Jun;36(6):481-7
10849088
Am J Pathol. 2000 Jun;156(6):1821-5
10854204
Am J Pathol. 2000 Jun;156(6):2123-33
10854233
Int J Pancreatol. 2000 Apr;27(2):93-103
10862508
Cancer. 2000 Jun 1;88(11):2495-504
10861425
Am J Pathol. 2000 Jul;157(1):83-92
10880379
J Pathol. 2000 Sep;192(1):81-9
10951404
Am J Pathol. 2000 Sep;157(3):755-61
10980115
Dig Dis. 2001;19(1):15-23
11385247
Virchows Arch. 2001 Jun;438(6):581-90
11469690
Virchows Arch. 2001 Dec;439(6):798-802
11787853
Mod Pathol. 2002 Apr;15(4):441-7
11950919
Hematol Oncol Clin North Am. 2002 Feb;16(1):1-16
12063821
Pancreatology. 2001;1(5):405-15
12120217
Pancreatology. 2001;1(6):581-6
12120240
Br J Cancer. 2002 Aug 27;87(5):551-4
12189555
Mod Pathol. 2001 Mar;14(3):139-46
11266517
Clin Cancer Res. 2001 Apr;7(4):812-7
11309327
Am J Pathol. 2001 May;158(5):1677-83
11337365
Am J Surg Pathol. 2001 May;25(5):579-86
11342768
Gastrointest Endosc. 2001 Jun;53(7):734-43
11375580
Int J Pancreatol. 1996 Oct;20(2):85-93
8968863
Surgery. 1997 Jan;121(1):42-9
9001550
Cancer Res. 1997 Jun 1;57(11):2140-3
9187111
Int J Pancreatol. 1997 Jun;21(3):205-17
9322119
Ann Surg. 1997 Oct;226(4):491-8; discussion 498-500
9351717
Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):515-21
9641496
Mutat Res. 1998 Sep 20;405(2):125-33
9748537
Pancreas. 1998 Nov;17(4):323-4
9821172
Cancer. 1999 Jan 15;85(2):326-32
10023699
Int J Cancer. 1999 Mar 15;80(6):827-41
10074914
Cancer. 1999 Apr 15;85(8):1703-10
10223563
Hum Pathol. 1999 Jun;30(6):602-10
10374765
Int J Clin Pharmacol Ther. 2002 Aug;40(8):354-67
12467304